Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cellectar Biosciences, Inc.
Ann & Robert H Lurie Children's Hospital of Chicago
Centre Oscar Lambret
University of Florida
Children's Oncology Group
M.D. Anderson Cancer Center
Columbia University
Medical College of Wisconsin